Clinical Trials Summary

Topic Study No. Clinical Trial Protocol Investigators
Parkinson's Disease - Fluctuators S187.3.002 A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson’s Subjects Receiving Optimized Treatments with Parkinson Medicinal Products Alberto J Espay (PI)
Newly Diagnosed Parkinson's Disease QE3 U01 NS 050324-01A1: Effects of Coenzyme Q10 in Parkinson Disease – Phase III Alok Sahay (PI)
Newly Diagnosed Parkinson's Disease STEADY-PD A pilot Phase II double blind placebo controlled two period dosage finding and early efficacy study of isradipine as a disease modifying agent in patients with early Parkinson disease Alok Sahay (PI)
Parkinson's Disease - Freezing of gait Medtronic Duration of Effect of Dynamic Visual and Auditory Feedback on Gait in Patients with Parkinson’s Disease Alberto J Espay (PI)
Parkinson's Disease - DBS - freezing of gait Investigator Initiated Effect of low versus high frequency subthalamic nucleus deep brain stimulation on freezing of gait in patients with Parkinson’s disease Andrew P Duker (PI)
Parkinson's Disease - DBS - mood Investigator Initiated Mapping Mood in the Subthalamic Nucleus in Parkinson’s Disease Protocol Fredy J Revilla (PI)
Advanced Parkinson's Disease IPX066-B09-02 Study to Evaluate the Safety and Efficacy of IPX066 in Advanced Parkinson’s Disease Alberto J Espay (PI)
Parkinson's Disease - Orthostatic Hypotension Droxidopa-301 A Multi-Center, Double-Blind, Randomized Placebo-Controlled, Parallel-Group, Induction-Design Study to Assess the Clinical Effect of Droxidopa in Subjects with Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency or Non-Diabetic Neuropathy and Alberto J Espay (PI)
Huntington's Disease 2CARE 2CARE-01.00 CoEnzyme Q10 in Huntington's Disease Fredy J Revilla (PI)
Huntington's Disease COHORT Cooperative Huntington’s Disease Observational Research Trial (COHORT) Fredy J Revilla (PI)